title: Universal hepatitis B vaccination: The only way to eliminate hepatocellular carcinoma?
authors.affiliation: Clinique Universitaire d'Hépato-Gastroentérologie, Pôle Digidune, CHU de Grenoble, France; Unité INSERM/Université Grenoble Alpes U823, IAPC Institut Albert Bonniot, Grenoble, France.
authors.forename: Vincent
authors.initials: V
authors.lastname: Leroy
authors.affiliation: Department of Hepatology, Hôpital Beaujon, AP-HP, Université Paris-Diderot, Clichy, France; Centre de Recherche sur l'Inflammation (CRI), UMR 1149 Inserm, Université Paris-Diderot, France. Electronic address: tarik.asselah@bjn.aphp.fr.
authors.forename: Tarik
authors.initials: T
authors.lastname: Asselah
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D006513:Hepatitis B e Antigens; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D014611:Vaccination
chemical_list: D000998:Antiviral Agents; D006513:Hepatitis B e Antigens
keywords: Asia; Entecavir; Epidemiology; Pegylated-IFN; Ribavirin; Tenofovir